Key result
Heterogeneous enhancement on MDCT immediately post-PCI is linked to ~14-fold higher MVO risk.
Why the study?
The study evaluated the clinical value of myocardial contrast-delayed enhancement with MDCT for detecting microvascular obstruction and LV remodelling after acute myocardial infarction.
Does heterogeneous enhancement detected by MDCT predict microvascular obstruction and left ventricular remodelling in patients with acute myocardial infarction after PCI?
Observational (n=92)
Does heterogeneous enhancement detected by MDCT predict microvascular obstruction and left ventricular remodelling in patients with acute myocardial infarction after PCI?
Answers are grounded in this paper and cite their sources.
Heterogeneous enhancement detected by MDCT immediately after primary PCI is a strong predictor of microvascular obstruction and subsequent left ventricular remodelling in patients with acute myocardial infarction.
AIMS: This study evaluated the clinical value of myocardial contrast-delayed enhancement (DE) with multidetector computed tomography (MDCT) for detecting microvascular obstruction (MVO) and left ventricular (LV) remodelling revealed by DE magnetic resonance imaging after acute myocardial infarction (AMI). METHODS AND RESULTS: In 92 patients with first AMI, MDCT without iodine reinjection was performed immediately following successful percutaneous coronary intervention (PCI). Delayed-enhancement magnetic resonance imaging performed in the acute and chronic phases was used to detect MVO and LV remodelling (any increase in LV end-systolic volume at 6 months after infarction compared with baseline). Patients were divided into two groups according to the presence (n = 33) or absence (n = 59) of heterogeneous enhancement (HE). Heterogeneous enhancement was defined as concomitant presence of hyper- and hypoenhancement within the infarcted myocardium on MDCT. Microvascular obstruction and LV remodelling were detected in 49 (53%) and 29 (32%) patients, respectively. In a multivariable analysis, HE and a relative CT density >2.20 were significant independent predictors for MVO [odds ratio (OR) 13.5; 95% confidence interval (CI), 2.15-84.9; P = 0.005 and OR 12.0; 95% CI, 2.94-49.2; P < 0.001, respectively). The presence of HE and relative CT density >2.20 showed a high positive predictive value of 93%, and the absence of these two findings yielded a high negative predictive value of 90% for the predictive value of MVO. Heterogeneous enhancement was significantly associated with LV remodelling (OR 6.75; 95% CI, 1.56-29.29; P = 0.011). CONCLUSION: Heterogeneous enhancement detected by MDCT immediately after primary PCI may provide promising information for predicting MVO and LV remodelling in patients with AMI.
No takes yet. Share an insight, caveat, or question.
Watabe et al. (2015) conducted an observational in Acute myocardial infarction (n=92). Heterogeneous enhancement on MDCT vs. Absence of heterogeneous enhancement was evaluated on Microvascular obstruction (MVO) (OR 13.5, 95% CI 2.15-84.9, p=0.005). Heterogeneous enhancement on MDCT immediately after primary PCI was a significant independent predictor of microvascular obstruction.
Synapse has enriched 10 related papers. Consider them for comparative context: